Human infection with a novel tick-borne Anaplasma species in China: A surveillance study

Hao Li, Yuan Chun Zheng, Lan Ma, Na Jia, Bao Gui Jiang, Rui Ruo Jiang, Qiu Bo Huo, Ya Wei Wang, Hong Bo Liu, Yan Li Chu, Yu Dong Song, Nan Nan Yao, Tie Sun, Fan Yi Zeng, J. Stephen Dumler, Jia Fu Jiang, Wu Chun Cao

Research output: Contribution to journalArticle

Abstract

Background: Anaplasma phagocytophilum and Anaplasma ovis cause human infections. We investigated the potential for human pathogenicity of a newly discovered Anaplasma species infecting goats in China. Methods: We collected blood samples from patients with a history of tick bite in the preceding 2 months at Mudanjiang Forestry Central Hospital of Heilongjiang Province from May 1, to June 10, 2014, to detect the novel Anaplasma species by PCR. We inoculated positive samples into cell cultures. We characterised the isolated pathogen by morphological and phylogenetic analyses. We tested serum antibodies by indirect immunofluorescence assay. Findings: 28 (6%) of 477 patients assessed were infected with the novel Anaplasma species according to PCR and sequencing. We isolated the pathogen in vitro from three patients. Phylogenetic analyses of rrs, gltA, groEL, msp2, and msp4 showed that the pathogen was distinct from all known Anaplasma species. We provisionally nominate it ". Anaplasma capra". 22 (92%) of 24 patients with data available had seroconversion or a four-fold increase in antibody titres. All 28 patients developed non-specific febrile manifestations, including fever in 23 (82%), headache in 14 (50%), malaise in 13 (46%), dizziness in nine (32%), myalgia in four (14%), and chills in four (14%). Additionally, ten (36%) of 28 patients had rash or eschar, eight (29%) had lymphadenopathy, eight (29%) had gastrointestinal symptoms, and three (11%) had stiff neck. Five patients were admitted to hospital because of severe disease. Six (35%) of 17 patients with data available had high hepatic aminotransferase concentrations. Interpretation: The emergence of ". A capra" as a cause of human disease suggests that individuals living in or travelling to endemic regions in northern China should take precautions to reduce their risk of exposure to this novel tick-borne pathogen. Funding: Natural Science Foundation of China and the US National Institutes of Health.

Original languageEnglish (US)
Pages (from-to)663-670
Number of pages8
JournalLancet Infectious Diseases
Volume15
Issue number6
DOIs
StatePublished - Jun 1 2015
Externally publishedYes

Fingerprint

Anaplasma
Ticks
China
Infection
Goats
Anaplasma ovis
Fever
Anaplasma phagocytophilum
Tick Bites
Natural Science Disciplines
Forestry
Polymerase Chain Reaction
Chills
Antibodies
Myalgia
National Institutes of Health (U.S.)
Dizziness
Indirect Fluorescent Antibody Technique
Transaminases
Exanthema

ASJC Scopus subject areas

  • Infectious Diseases
  • Medicine(all)

Cite this

Li, H., Zheng, Y. C., Ma, L., Jia, N., Jiang, B. G., Jiang, R. R., ... Cao, W. C. (2015). Human infection with a novel tick-borne Anaplasma species in China: A surveillance study. Lancet Infectious Diseases, 15(6), 663-670. https://doi.org/10.1016/S1473-3099(15)70051-4

Human infection with a novel tick-borne Anaplasma species in China : A surveillance study. / Li, Hao; Zheng, Yuan Chun; Ma, Lan; Jia, Na; Jiang, Bao Gui; Jiang, Rui Ruo; Huo, Qiu Bo; Wang, Ya Wei; Liu, Hong Bo; Chu, Yan Li; Song, Yu Dong; Yao, Nan Nan; Sun, Tie; Zeng, Fan Yi; Dumler, J. Stephen; Jiang, Jia Fu; Cao, Wu Chun.

In: Lancet Infectious Diseases, Vol. 15, No. 6, 01.06.2015, p. 663-670.

Research output: Contribution to journalArticle

Li, H, Zheng, YC, Ma, L, Jia, N, Jiang, BG, Jiang, RR, Huo, QB, Wang, YW, Liu, HB, Chu, YL, Song, YD, Yao, NN, Sun, T, Zeng, FY, Dumler, JS, Jiang, JF & Cao, WC 2015, 'Human infection with a novel tick-borne Anaplasma species in China: A surveillance study', Lancet Infectious Diseases, vol. 15, no. 6, pp. 663-670. https://doi.org/10.1016/S1473-3099(15)70051-4
Li, Hao ; Zheng, Yuan Chun ; Ma, Lan ; Jia, Na ; Jiang, Bao Gui ; Jiang, Rui Ruo ; Huo, Qiu Bo ; Wang, Ya Wei ; Liu, Hong Bo ; Chu, Yan Li ; Song, Yu Dong ; Yao, Nan Nan ; Sun, Tie ; Zeng, Fan Yi ; Dumler, J. Stephen ; Jiang, Jia Fu ; Cao, Wu Chun. / Human infection with a novel tick-borne Anaplasma species in China : A surveillance study. In: Lancet Infectious Diseases. 2015 ; Vol. 15, No. 6. pp. 663-670.
@article{69832c682e384e1f8ff57af5f2770fbc,
title = "Human infection with a novel tick-borne Anaplasma species in China: A surveillance study",
abstract = "Background: Anaplasma phagocytophilum and Anaplasma ovis cause human infections. We investigated the potential for human pathogenicity of a newly discovered Anaplasma species infecting goats in China. Methods: We collected blood samples from patients with a history of tick bite in the preceding 2 months at Mudanjiang Forestry Central Hospital of Heilongjiang Province from May 1, to June 10, 2014, to detect the novel Anaplasma species by PCR. We inoculated positive samples into cell cultures. We characterised the isolated pathogen by morphological and phylogenetic analyses. We tested serum antibodies by indirect immunofluorescence assay. Findings: 28 (6{\%}) of 477 patients assessed were infected with the novel Anaplasma species according to PCR and sequencing. We isolated the pathogen in vitro from three patients. Phylogenetic analyses of rrs, gltA, groEL, msp2, and msp4 showed that the pathogen was distinct from all known Anaplasma species. We provisionally nominate it {"}. Anaplasma capra{"}. 22 (92{\%}) of 24 patients with data available had seroconversion or a four-fold increase in antibody titres. All 28 patients developed non-specific febrile manifestations, including fever in 23 (82{\%}), headache in 14 (50{\%}), malaise in 13 (46{\%}), dizziness in nine (32{\%}), myalgia in four (14{\%}), and chills in four (14{\%}). Additionally, ten (36{\%}) of 28 patients had rash or eschar, eight (29{\%}) had lymphadenopathy, eight (29{\%}) had gastrointestinal symptoms, and three (11{\%}) had stiff neck. Five patients were admitted to hospital because of severe disease. Six (35{\%}) of 17 patients with data available had high hepatic aminotransferase concentrations. Interpretation: The emergence of {"}. A capra{"} as a cause of human disease suggests that individuals living in or travelling to endemic regions in northern China should take precautions to reduce their risk of exposure to this novel tick-borne pathogen. Funding: Natural Science Foundation of China and the US National Institutes of Health.",
author = "Hao Li and Zheng, {Yuan Chun} and Lan Ma and Na Jia and Jiang, {Bao Gui} and Jiang, {Rui Ruo} and Huo, {Qiu Bo} and Wang, {Ya Wei} and Liu, {Hong Bo} and Chu, {Yan Li} and Song, {Yu Dong} and Yao, {Nan Nan} and Tie Sun and Zeng, {Fan Yi} and Dumler, {J. Stephen} and Jiang, {Jia Fu} and Cao, {Wu Chun}",
year = "2015",
month = "6",
day = "1",
doi = "10.1016/S1473-3099(15)70051-4",
language = "English (US)",
volume = "15",
pages = "663--670",
journal = "The Lancet Infectious Diseases",
issn = "1473-3099",
publisher = "Lancet Publishing Group",
number = "6",

}

TY - JOUR

T1 - Human infection with a novel tick-borne Anaplasma species in China

T2 - A surveillance study

AU - Li, Hao

AU - Zheng, Yuan Chun

AU - Ma, Lan

AU - Jia, Na

AU - Jiang, Bao Gui

AU - Jiang, Rui Ruo

AU - Huo, Qiu Bo

AU - Wang, Ya Wei

AU - Liu, Hong Bo

AU - Chu, Yan Li

AU - Song, Yu Dong

AU - Yao, Nan Nan

AU - Sun, Tie

AU - Zeng, Fan Yi

AU - Dumler, J. Stephen

AU - Jiang, Jia Fu

AU - Cao, Wu Chun

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Background: Anaplasma phagocytophilum and Anaplasma ovis cause human infections. We investigated the potential for human pathogenicity of a newly discovered Anaplasma species infecting goats in China. Methods: We collected blood samples from patients with a history of tick bite in the preceding 2 months at Mudanjiang Forestry Central Hospital of Heilongjiang Province from May 1, to June 10, 2014, to detect the novel Anaplasma species by PCR. We inoculated positive samples into cell cultures. We characterised the isolated pathogen by morphological and phylogenetic analyses. We tested serum antibodies by indirect immunofluorescence assay. Findings: 28 (6%) of 477 patients assessed were infected with the novel Anaplasma species according to PCR and sequencing. We isolated the pathogen in vitro from three patients. Phylogenetic analyses of rrs, gltA, groEL, msp2, and msp4 showed that the pathogen was distinct from all known Anaplasma species. We provisionally nominate it ". Anaplasma capra". 22 (92%) of 24 patients with data available had seroconversion or a four-fold increase in antibody titres. All 28 patients developed non-specific febrile manifestations, including fever in 23 (82%), headache in 14 (50%), malaise in 13 (46%), dizziness in nine (32%), myalgia in four (14%), and chills in four (14%). Additionally, ten (36%) of 28 patients had rash or eschar, eight (29%) had lymphadenopathy, eight (29%) had gastrointestinal symptoms, and three (11%) had stiff neck. Five patients were admitted to hospital because of severe disease. Six (35%) of 17 patients with data available had high hepatic aminotransferase concentrations. Interpretation: The emergence of ". A capra" as a cause of human disease suggests that individuals living in or travelling to endemic regions in northern China should take precautions to reduce their risk of exposure to this novel tick-borne pathogen. Funding: Natural Science Foundation of China and the US National Institutes of Health.

AB - Background: Anaplasma phagocytophilum and Anaplasma ovis cause human infections. We investigated the potential for human pathogenicity of a newly discovered Anaplasma species infecting goats in China. Methods: We collected blood samples from patients with a history of tick bite in the preceding 2 months at Mudanjiang Forestry Central Hospital of Heilongjiang Province from May 1, to June 10, 2014, to detect the novel Anaplasma species by PCR. We inoculated positive samples into cell cultures. We characterised the isolated pathogen by morphological and phylogenetic analyses. We tested serum antibodies by indirect immunofluorescence assay. Findings: 28 (6%) of 477 patients assessed were infected with the novel Anaplasma species according to PCR and sequencing. We isolated the pathogen in vitro from three patients. Phylogenetic analyses of rrs, gltA, groEL, msp2, and msp4 showed that the pathogen was distinct from all known Anaplasma species. We provisionally nominate it ". Anaplasma capra". 22 (92%) of 24 patients with data available had seroconversion or a four-fold increase in antibody titres. All 28 patients developed non-specific febrile manifestations, including fever in 23 (82%), headache in 14 (50%), malaise in 13 (46%), dizziness in nine (32%), myalgia in four (14%), and chills in four (14%). Additionally, ten (36%) of 28 patients had rash or eschar, eight (29%) had lymphadenopathy, eight (29%) had gastrointestinal symptoms, and three (11%) had stiff neck. Five patients were admitted to hospital because of severe disease. Six (35%) of 17 patients with data available had high hepatic aminotransferase concentrations. Interpretation: The emergence of ". A capra" as a cause of human disease suggests that individuals living in or travelling to endemic regions in northern China should take precautions to reduce their risk of exposure to this novel tick-borne pathogen. Funding: Natural Science Foundation of China and the US National Institutes of Health.

UR - http://www.scopus.com/inward/record.url?scp=84929515581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929515581&partnerID=8YFLogxK

U2 - 10.1016/S1473-3099(15)70051-4

DO - 10.1016/S1473-3099(15)70051-4

M3 - Article

C2 - 25833289

AN - SCOPUS:84929515581

VL - 15

SP - 663

EP - 670

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

SN - 1473-3099

IS - 6

ER -